JPH0520411B2 - - Google Patents

Info

Publication number
JPH0520411B2
JPH0520411B2 JP59102622A JP10262284A JPH0520411B2 JP H0520411 B2 JPH0520411 B2 JP H0520411B2 JP 59102622 A JP59102622 A JP 59102622A JP 10262284 A JP10262284 A JP 10262284A JP H0520411 B2 JPH0520411 B2 JP H0520411B2
Authority
JP
Japan
Prior art keywords
phospholipids
phospholipid
lecithin
cosmetic
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP59102622A
Other languages
Japanese (ja)
Other versions
JPS60246305A (en
Inventor
Juzo Higaki
Masato Nakazato
Kyoko Kamyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Oillio Group Ltd
Original Assignee
Nisshin Oil Mills Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Oil Mills Ltd filed Critical Nisshin Oil Mills Ltd
Priority to JP59102622A priority Critical patent/JPS60246305A/en
Publication of JPS60246305A publication Critical patent/JPS60246305A/en
Publication of JPH0520411B2 publication Critical patent/JPH0520411B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/064Water-in-oil emulsions, e.g. Water-in-silicone emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair

Description

【発明の詳細な説明】[Detailed description of the invention]

産業上の利用分野 本発明は、ホスフアチジルイノシトールを配合
してなるか、または当該物質に富んだリン脂質を
配合してなる化粧料に係る。 従来の技術 リン脂質は動植物生体に広く分布し、とりわけ
脳、神経、肝臓、血液など生物にとつて重要な働
きをする組織にとくに多量に含まれており、各種
の生理的機能を果している。このことからリン脂
質は動脈硬化症、高脂血症、肝臓病、心臓病等の
治療剤、食品、香粧品、医薬品等の乳化剤等に利
用されている。 通常リン脂質は植物種子から油脂を抽出、精製
するときにガム質として分離、精製されてつくら
れるが種子原料の種類により含有されるリン脂質
の組成が異なる。 通常植物種子中のリン脂質組成は、ホスフアチ
ジルコリン(以下PCという)、ホスフアチジルエ
タノールアミン(以下PEという)、ホスフアチジ
ルイノシトール(以下PIという)が主体であり、
例えば植物性リン脂質の代表である大豆リン脂質
の場合通常PC20〜25%、PE15〜20%、PI12〜17
%の組成であつて、これらの混合物のまま使用さ
れることが多い。また分画したレシチンを使用す
る場合もあり、この場合の分画レシチンはエタノ
ール等のアルコールで抽出した抽出物、すなわち
PCが主体(50〜60%)となり、その他PE、ホス
フアチジルセリン等が含有されている。このよう
な例として前記分画レシチンとN−アシルグルタ
ミン酸塩とを含有する洗浄剤組成物が知られてい
る(特公昭52−10457号公報)。この場合の分画レ
シチンは親水性の高いPCが主体となり、O/W
型乳化には適している。 以上の植物種子由来のリン脂質の他に、卵黄レ
シチンに代表される植物性リン脂質があるが、市
販の卵黄レシチンは、リン脂質組成がPC65〜75
%、PE13〜18、P11〜2%であり、この場合も
前記分画レシチンと同様にPCが主体のリン脂質
であり、使用方法も同様である。 従来のリン脂質は以上の通りであるが、まず混
合リン脂質は、その性質が単一であるため多様な
性能を要求される化粧料には必らずしも適さな
い。またそれらの混合リン脂質からアルコール分
画で得たPC含量の高いレシチンは親水性は高く
なりO/W型乳化には問題があるため、W/O型
乳化には問題があるため、W/O型化粧料には使
用できない。さらに動物性リン脂質は高価で量的
にも確保するのが難しく、汎用の化粧品原料とし
ては不適当である。 発明が解決しようとする問題点 本発明の目的は、前記したリン脂質の欠点を排
除し、かつ従来のリン脂質では得られない優れた
特性を持つた化粧料を得ることにある。従来リン
脂質として、特にPCを主眼にして検討されてお
り、また実際にPCを濃縮、分画したタイプ等の
乳化性、可溶化性等についての改良が主体であつ
た。本発明者らは、PC以外のリン脂質に着目し、
PIを濃縮、分画したリン脂質が、特にW/O型
乳化に適し、かつ顔料、色素分散性、毛髪処理剤
として優れていることを見い出し、本発明に到達
した。 問題点を解決するための手段 本発明はPIを25重量%以上含有するリン脂質
を含有してなる化粧料に係る。 本発明で使用するリン脂質は動植物リン脂質の
いずれからPIを濃縮、分離したものでもよいが、
原料、価格等の面から植物性リン脂質からのもの
が好ましい。植物性リン脂質としては、特に大
豆、なたね、ひまわり、サフラワー、綿実、とう
もろこし、アマニ、ゴマ、オリーブ、米、キリ、
グレープ、アボガド、ヤシおよびパームから選ば
れる1種または2種以上の植物原料から得られる
リン脂質が適当であり、本発明ではこれらから
PIを濃縮、分離したものが好ましい。 一般に植物原料から得られるリン脂質は、不純
物としてかなりの量の中性脂肪が含まれている。
近年になつて、中性脂肪を除去したリン脂質(高
純度レシチンという)が市販されるようになり、
このものは固体状で吸湿性の高い粉末となるが、
本発明においては、以上のいずれのリン脂質も原
料とすることができる。一般に市販されている汎
用レシチンとして大豆リン脂質があり、本発明で
使用する濃縮、分画したPI濃縮物の原料として
量、価格、品質等の点からこのものがより好まし
い。 PIを濃縮分画する方法は、メタノール、エタ
ノール、プロパノール等の低級アルコール及びそ
れらの含水アルコールでPC,PE等の親水性の高
いリン脂質を抽出除去し、PIを濃縮、分画する。
また無水酢酸で主にPEをアセチル化し、アセチ
ル化リン脂質をアセトンで除去して、PIをさら
に濃縮、分画することもできる。リン脂質から濃
宿、分画されたPIのリン脂質中の含量は低濃度
の場合、混合リン脂質とあまり性能的に差がな
く、25重量%以上の濃度が必要である。PIが25
重量%未満であるとW/O型乳化には適さなくな
り、化粧料としての適性が狭くなる。 かくして得られるPIの濃縮分画レシチンは化
粧料の乳化剤、保湿剤、エモリエント剤等として
使われている界面活性剤の全部または一部として
用いることができる。配分量は、一般には化粧料
全量に対して0.05〜10重量%である。 化粧料の種類は特に制限はなく、コールドクリ
ーム、バニツシングクリーム等のクリーム類、乳
液、ローシヨン、パツク剤、シヤンプー、リン
ス、ヘアートリートメント、口紅、ほほ紅、パウ
ンドケーキ、アイシヤドー等に適用することがで
きる。 作 用 本発明におけるPIの濃縮、分画レシチンは、
レシチン特有の両性界面活性剤としての機能、即
ち優れた乳化性、保湿性、エモリエント性を有
し、安全性が高い物質であり、とくにW/O型乳
化剤、顔料、色素の分散剤、毛髪処理剤として優
れている。 実施例1 ホスフアチジルイノシトールの濃縮、
分画 (1) ペースト状大豆リン脂質(アセトン不溶分63
%、ヨウ素価78)500g93%メタノール3で
40℃に撹拌抽出した。引続きメタノール層と油
層を分離させ、油層を脱溶剤して、ペースト状
褐色物質305gを得た。得られた褐色物質はア
セトン不溶分71%、ヨウ素価75、リン脂質組
成:PC10.5%、PE20.3%、PI25.5%であつた
(以下試料という)。 (2) 高純度大豆レシチン(アセトン不溶分97.5
%、ヨウ素価84)500gをエタノール/メタノ
ール=86/14(重量比)の95%混合アルコール
2.5で45℃にて撹拌、抽出を行つた。引続き
(1)と同一の処理を施して、黄色粉末330gを得
た。アセトン不溶分96.3%、ヨウ素価82、リン
脂質組成:PC8.5%、PE22.4%、PI27.5%であ
つた。(以下試料という)。 (3) 試料100gをヘキサン200mlに溶解させ無水
酢酸20mlを加え、70℃で2時間撹拌した。引続
き溶剤を留去後、アセトン1を加えよく撹拌
した後、生じた黄色粉末物質を濾別し、さらに
乾燥して、黄白状粉末物質65gを得た。アセト
ン不溶分98.2%、ヨウ素価83、リン脂質組成:
PC9.0%、PE1.2%、PI51.7%であつた(以下
試料という)。 (4) 試料40gを95%エタノールで30℃にて撹拌
抽出後(1)と同一の処理を施して黄色粉末32gを
得た。アセトン不溶分97.6%、ヨウ素価80、リ
ン脂質組成:PC1.5%、PE2.2%、PI62.5%で
あつた(以下試料という)。 (5) 高純度なたねレシチン(アセトン不溶分96.8
%、ヨウ素価75)300gを98%イソプロパノー
ル溶液1.2で30℃にて撹拌抽出した。引続き
(1)と同一の処理を施して黄褐色粉末185gを得
た。アセトン不溶分95.2%、ヨウ素価76、リン
脂質組成:PC12.0%、PE20.2%、PI39.5%で
あつた(以下試料という)。 実施例2 配合例 2−1 エモリエントクリーム(W/O型) マイクロクリスタリンワツクス
9.0%(重量。以下同様) パラフイン 2.0 ミツロウ 3.0 ワセリン 5.0 還元ラノリン 8.0 スクワラン 32.0 イソオクチル酸グリセリド 10.0 プロピレングリコール 2.0 試料 5.5 ポリオキシエチレンソルビタンモノオレイン酸
エステル(20E.0) 1.0 香料、防腐剤、酸化防止剤 適量 精製水 全量100% 2−2 エモリエントローシヨン(W/O型) マイクロクリスタリンワツクス 1.0% ミツロウ 2.0 ラノリン 2.0 流動パラフイン 30.0 グリセリン 7.5 試料 4.5 ポリオキシエチレンソルビタンモノオレイン酸
エステル(20E.0) 1.0 ステアリン酸アルミニウム 0.2 香料、防腐剤、酸化防止剤 適量 精製水 全量100% 2−3 アイライナー タルク 40.0% 酸化チタン 5.0 沈降炭酸カルシウム 10.0 顔料 30.0 グリセリン 2.0 流動パラフイン 10.0 試料 3.0 防腐剤、酸化防止剤 適量 2−4 コンデイシヨニングシヤンプー アルキルエーテル硫酸ナトリウム(AES−
Na) 18.0% ヤシ脂肪酸ジエタノールアミド 2.0 陽イオン変性セルロースエーテル 1.5 試料 1.0 防腐剤、色素、香料 適量 精製水 全量100% 2−5 コンデイシヨニングリンス 変性デンプン 2.0% ポリオキシエチレンコレステロール 1.0 試料 2.0 シリコール 0.2 香料、色素、防腐剤 適量 精製水 全量100% 発明の効果 実施例2で示した各種化粧料はいずれも感触的
に良好で乳化特性がよく、化粧料として優れてい
ることが認められた。 配合例2−1,2−2に示すクリーム、ローシ
ヨンと市販品A(エモリエントクリーム)、市販B
(エモリエントローシヨン)の官能的優劣を女性
30人に2週間連用させて得られた結果(回収率90
%)を第1表に示す。
INDUSTRIAL APPLICATION FIELD The present invention relates to cosmetics containing phosphatidylinositol or containing phospholipids rich in this substance. BACKGROUND OF THE INVENTION Phospholipids are widely distributed in living organisms, animals and plants, and are contained in particularly large amounts in tissues that play an important role in living things, such as the brain, nerves, liver, and blood, and perform various physiological functions. For this reason, phospholipids are used as therapeutic agents for arteriosclerosis, hyperlipidemia, liver disease, heart disease, etc., and as emulsifiers for foods, cosmetics, pharmaceuticals, and the like. Normally, phospholipids are produced by separating and refining oils and fats from plant seeds as a gum, but the composition of the phospholipids differs depending on the type of seed material. The phospholipid composition in normal plant seeds is mainly composed of phosphatidylcholine (hereinafter referred to as PC), phosphatidylethanolamine (hereinafter referred to as PE), and phosphatidylinositol (hereinafter referred to as PI).
For example, soybean phospholipids, which are representative of vegetable phospholipids, usually have a PC of 20-25%, a PE of 15-20%, and a PI of 12-17.
% composition, and these mixtures are often used as is. Fractionated lecithin may also be used; in this case, fractionated lecithin is an extract extracted with alcohol such as ethanol, i.e.
PC is the main component (50-60%), and other substances such as PE and phosphatidylserine are also contained. As an example of this, a detergent composition containing the fractionated lecithin and N-acylglutamate is known (Japanese Patent Publication No. 10457/1983). In this case, the fractionated lecithin is mainly composed of highly hydrophilic PC, and O/W
Suitable for mold emulsification. In addition to the above-mentioned phospholipids derived from plant seeds, there are vegetable phospholipids represented by egg yolk lecithin, but commercially available egg yolk lecithin has a phospholipid composition of PC65-75.
%, PE13 to 18, and P11 to 2%, and in this case as well, it is a phospholipid mainly composed of PC as in the case of the fractionated lecithin, and the method of use is also the same. Conventional phospholipids are as described above, but mixed phospholipids have a single property, so they are not necessarily suitable for cosmetics that require a variety of performances. In addition, lecithin with a high PC content obtained by alcohol fractionation from these mixed phospholipids has high hydrophilicity and has problems with O/W type emulsification; Cannot be used in type O cosmetics. Furthermore, animal phospholipids are expensive and difficult to obtain in quantity, making them unsuitable as general-purpose cosmetic raw materials. Problems to be Solved by the Invention An object of the present invention is to eliminate the above-mentioned drawbacks of phospholipids and to obtain a cosmetic that has excellent properties that cannot be obtained with conventional phospholipids. Conventionally, studies have focused on PC as a phospholipid, and the main focus has been on improving the emulsifying and solubilizing properties of PC-concentrated and fractionated types. The present inventors focused on phospholipids other than PC,
The present invention was accomplished by discovering that phospholipids obtained by concentrating and fractionating PI are particularly suitable for W/O emulsification, and are excellent in pigment, dye dispersibility, and as a hair treatment agent. Means for Solving the Problems The present invention relates to a cosmetic containing a phospholipid containing 25% by weight or more of PI. The phospholipid used in the present invention may be one obtained by concentrating and separating PI from any animal or plant phospholipid, but
From the viewpoint of raw materials, cost, etc., those made from vegetable phospholipids are preferred. Plant-based phospholipids include soybeans, rapeseed, sunflowers, safflower, cottonseed, corn, flaxseed, sesame, olives, rice, thorns,
Phospholipids obtained from one or more plant materials selected from grape, avocado, coconut, and palm are suitable, and in the present invention, phospholipids obtained from these
Preferably, PI is concentrated and separated. Generally, phospholipids obtained from plant materials contain a considerable amount of neutral fat as an impurity.
In recent years, phospholipids from which neutral fats have been removed (called high-purity lecithin) have become commercially available.
This material is a solid, highly hygroscopic powder,
In the present invention, any of the above phospholipids can be used as a raw material. Soybean phospholipid is a commercially available general-purpose lecithin, and this is more preferable as a raw material for the concentrated and fractionated PI concentrate used in the present invention in terms of quantity, price, quality, etc. The method for concentrating and fractionating PI involves extracting and removing highly hydrophilic phospholipids such as PC and PE using lower alcohols such as methanol, ethanol, and propanol and their hydrous alcohols, and then concentrating and fractionating PI.
It is also possible to further concentrate and fractionate PI by mainly acetylating PE with acetic anhydride and removing acetylated phospholipids with acetone. When the content of PI concentrated and fractionated from phospholipids in phospholipids is low, there is not much difference in performance from mixed phospholipids, and a concentration of 25% by weight or more is required. PI is 25
If it is less than % by weight, it will not be suitable for W/O type emulsification, and its suitability as a cosmetic will be limited. The concentrated fractionated lecithin of PI thus obtained can be used in whole or in part as a surfactant used as an emulsifier, humectant, emollient, etc. in cosmetics. The amount to be distributed is generally 0.05 to 10% by weight based on the total amount of the cosmetic. There are no particular restrictions on the type of cosmetics, and the application may be applied to creams such as cold cream, vanishing cream, emulsion, lotion, face pack, shampoo, conditioner, hair treatment, lipstick, blusher, pound cake, eye shadow, etc. I can do it. Effects The concentrated and fractionated lecithin of PI in the present invention is
Lecithin has a unique function as an amphoteric surfactant, that is, it has excellent emulsifying properties, moisturizing properties, and emollient properties, and is a highly safe substance, especially as a W/O type emulsifier, pigment, dispersant for pigments, and hair treatment. Excellent as an agent. Example 1 Concentration of phosphatidylinositol,
Fraction (1) Pasty soybean phospholipid (acetone insoluble fraction 63
%, iodine value 78) 500g 93% methanol 3
The mixture was stirred and extracted at 40°C. Subsequently, the methanol layer and the oil layer were separated, and the oil layer was removed from the solvent to obtain 305 g of a pasty brown substance. The obtained brown substance had an acetone insoluble content of 71%, an iodine value of 75, and a phospholipid composition of 10.5% PC, 20.3% PE, and 25.5% PI (hereinafter referred to as the sample). (2) High purity soybean lecithin (acetone insoluble content 97.5
%, iodine value 84) 500g of 95% mixed alcohol of ethanol/methanol = 86/14 (weight ratio)
Stirring and extraction were performed at 45°C under 2.5°C. Continued
The same treatment as in (1) was performed to obtain 330 g of yellow powder. The acetone insoluble content was 96.3%, the iodine value was 82, and the phospholipid composition was 8.5% PC, 22.4% PE, and 27.5% PI. (hereinafter referred to as the sample). (3) 100 g of the sample was dissolved in 200 ml of hexane, 20 ml of acetic anhydride was added, and the mixture was stirred at 70°C for 2 hours. Subsequently, after distilling off the solvent, 1 part of acetone was added and the mixture was thoroughly stirred. The resulting yellow powder substance was filtered off and further dried to obtain 65 g of a yellowish white powder substance. Acetone insoluble content 98.2%, iodine value 83, phospholipid composition:
The contents were 9.0% PC, 1.2% PE, and 51.7% PI (hereinafter referred to as the sample). (4) 40 g of the sample was extracted with 95% ethanol at 30° C. with stirring, and then subjected to the same treatment as in (1) to obtain 32 g of yellow powder. The acetone insoluble content was 97.6%, the iodine value was 80, and the phospholipid composition was 1.5% PC, 2.2% PE, and 62.5% PI (hereinafter referred to as the sample). (5) High purity rapeseed lecithin (acetone insoluble content 96.8
%, iodine value 75) was extracted with stirring at 30°C with 1.2% of a 98% isopropanol solution. Continued
The same treatment as in (1) was performed to obtain 185 g of yellowish brown powder. The acetone insoluble content was 95.2%, the iodine value was 76, and the phospholipid composition was 12.0% PC, 20.2% PE, and 39.5% PI (hereinafter referred to as the sample). Example 2 Formulation example 2-1 Emollient cream (W/O type) Microcrystalline wax
9.0% (weight) Paraffin 2.0 Beeswax 3.0 Vaseline 5.0 Reduced lanolin 8.0 Squalane 32.0 Isooctylic acid glyceride 10.0 Propylene glycol 2.0 Sample 5.5 Polyoxyethylene sorbitan monooleate (20E.0) 1.0 Fragrance, preservative, antioxidant Appropriate amount Purified water Total amount 100% 2-2 Emollient lotion (W/O type) Microcrystalline wax 1.0% Beeswax 2.0 Lanolin 2.0 Liquid paraffin 30.0 Glycerin 7.5 Sample 4.5 Polyoxyethylene sorbitan monooleate (20E.0) 1.0 Stearin Aluminum acid 0.2 Fragrance, preservative, antioxidant Appropriate amount Purified water Total amount 100% 2-3 Eyeliner talc 40.0% Titanium oxide 5.0 Precipitated calcium carbonate 10.0 Pigment 30.0 Glycerin 2.0 Liquid paraffin 10.0 Sample 3.0 Preservative, Antioxidant Appropriate amount 2-3 4 Conditioning shampoo Sodium alkyl ether sulfate (AES-
Na) 18.0% Coconut fatty acid diethanolamide 2.0 Cation modified cellulose ether 1.5 Sample 1.0 Preservatives, pigments, fragrances Appropriate amount Purified water Total amount 100% 2-5 Conditioning rinse Modified starch 2.0% Polyoxyethylene cholesterol 1.0 Sample 2.0 Silicone 0.2 Perfumes, pigments, preservatives Appropriate amounts Purified water Total amount 100% Effects of the invention All of the various cosmetics shown in Example 2 had a good texture and good emulsifying properties, and were recognized to be excellent as cosmetics. Creams and lotions shown in Formulation Examples 2-1 and 2-2, commercial product A (emollient cream), and commercial product B
(emollient lotion) to show the sensual superiority and inferiority of women
Results obtained after 30 people used it continuously for 2 weeks (response rate 90
%) are shown in Table 1.

【表】 第1表から本発明によるクリームの官能評価は
非常に優れていることがわかる。また配合例2−
4、2−5に示すシヤンプー、リンスと市販品C
(コンデイシヨニングシヤンプー)、市販品D(コ
ンデイシヨニングリンス)の官能的優劣を男女50
人に使用させて得られた結果(回収率80%)を第
2表に示す。
[Table] From Table 1, it can be seen that the cream according to the present invention had an excellent sensory evaluation. Also, blending example 2-
4. Shampoo, rinse and commercial product C shown in 2-5
(Conditioning Shampoo) and Commercial Product D (Conditioning Rinse) for men and women.
Table 2 shows the results obtained from human use (recovery rate 80%).

【表】 第2表から本発明によるシヤンプーおよびリン
スの官能評価は非常に優れていることがわかる。
Table 2 shows that the shampoo and rinse according to the present invention had excellent sensory evaluations.

Claims (1)

【特許請求の範囲】 1 ホスフアチジルイノシトールを25重量%以上
含有するリン脂質を配合してなる化粧料。 2 りん脂質が大豆、なたね、ひまわり、サフラ
ワー、綿実、とうもろこし、アマニ、ゴマ、オリ
ーブ、米、キリ、グレープ、アボガド、ヤシおよ
びパームから選ばれる1種または2種以上の植物
原料から得られる植物性レシチンからホスフアチ
ジルイノシトールを濃縮、分画して得られるもの
である特許請求の範囲第1項記載の化粧料。 3 化粧料がW/O型乳化物である特許請求の範
囲第1項記載の化粧料。
[Scope of Claims] 1. A cosmetic containing a phospholipid containing 25% by weight or more of phosphatidylinositol. 2. The phospholipid is obtained from one or more plant materials selected from soybean, rapeseed, sunflower, safflower, cottonseed, corn, flaxseed, sesame, olive, rice, thorn, grape, avocado, coconut, and palm. The cosmetic according to claim 1, which is obtained by concentrating and fractionating phosphatidylinositol from vegetable lecithin. 3. The cosmetic according to claim 1, wherein the cosmetic is a W/O emulsion.
JP59102622A 1984-05-23 1984-05-23 Cosmetic Granted JPS60246305A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59102622A JPS60246305A (en) 1984-05-23 1984-05-23 Cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59102622A JPS60246305A (en) 1984-05-23 1984-05-23 Cosmetic

Publications (2)

Publication Number Publication Date
JPS60246305A JPS60246305A (en) 1985-12-06
JPH0520411B2 true JPH0520411B2 (en) 1993-03-19

Family

ID=14332341

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59102622A Granted JPS60246305A (en) 1984-05-23 1984-05-23 Cosmetic

Country Status (1)

Country Link
JP (1) JPS60246305A (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5502345B2 (en) * 2009-03-03 2014-05-28 花王株式会社 Oil composition
US9962326B2 (en) 2010-08-19 2018-05-08 Johnson & Johnson Consumer Inc. Compositions comprising paulownia tomentosa wood extracts and uses thereof
KR20130099060A (en) * 2010-08-19 2013-09-05 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 Compositions comprising paulownin and/or paulownia extracts and uses thereof
US9387349B2 (en) 2010-08-19 2016-07-12 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9168219B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9168207B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9168279B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising paulownin and/or Paulownia extracts and uses thereof
US9161958B2 (en) 2010-08-19 2015-10-20 Johnson & Johnson Consumer Inc. Methods of treating cellulite
US9173913B2 (en) 2010-08-19 2015-11-03 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
KR20210107772A (en) 2018-12-26 2021-09-01 니폰 세이카 가부시키가이샤 Whitening agent, hyaluronic acid production promoter, collagen production promoter, intracellular active oxygen scavenger, irritation emollient, wrinkle improvement agent, complex, cosmetic and external skin agent

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5742326A (en) * 1980-07-25 1982-03-09 Oreal Stable o/w type emulsion
JPS58201708A (en) * 1982-05-18 1983-11-24 Asahi Chem Ind Co Ltd Cosmetic composition
JPS5955892A (en) * 1982-09-27 1984-03-31 Nisshin Oil Mills Ltd:The Stabilization of lecithin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5742326A (en) * 1980-07-25 1982-03-09 Oreal Stable o/w type emulsion
JPS58201708A (en) * 1982-05-18 1983-11-24 Asahi Chem Ind Co Ltd Cosmetic composition
JPS5955892A (en) * 1982-09-27 1984-03-31 Nisshin Oil Mills Ltd:The Stabilization of lecithin

Also Published As

Publication number Publication date
JPS60246305A (en) 1985-12-06

Similar Documents

Publication Publication Date Title
DE69839148T2 (en) USES OF OIL BODIES
CA2032106C (en) Cosmetic composition for hair care and use of the said composition
EP0709084B1 (en) Use of an oil rich in petroselinic acid as hydrating agent
US5466782A (en) Method for separating a compound containing glycolipids, lysophospholipids, sphingolipids and ceramides of plant origin
JPS58192828A (en) Nutritious composition and manufacture
EP0977550B1 (en) Use of at least one irvingia gabonensis extract in a cosmetic and/or pharmaceutical product
US6284257B1 (en) Cosmetic water emulsion containing at least one vegetable oil
FR2845287A1 (en) NOVEL COSMETIC FORMULATIONS BASED ON A THICKENING AGENT AND THEIR APPLICATIONS
JPH0520411B2 (en)
JP2000044485A (en) Active oxygen species scavenger and skin cosmetic
JP3035554B2 (en) Sterol ester
JPH06293614A (en) Lanoline fatty acid esters, cosmetic and external medicine
WO2016195142A1 (en) Method for producing natural nanoemulsion cosmetic composition containing moringa extract
KR102030310B1 (en) Cosmetic Composition Comprising Portulaca Oleracea and High Purity Octadecadienoic Acid
DE102005044186A1 (en) Cosmetic agent containing argan oil
JP2000247987A (en) Highly hydrogenated lecithin
EP1495798A1 (en) Natural emulsifying agent
JPS61204109A (en) Emulsion-type composition for external use
DE60225239T2 (en) Caramides, compositions containing them and their uses
JPH06279467A (en) Phospholipid composition
JPS5913709A (en) Moisturizer
EP1309305A2 (en) Cosmetic base complex
JP2004269433A (en) Cosmetic composition
JP2522943B2 (en) Anchovy extract
JPS62238207A (en) Cosmetic

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees